Patients with chronic kidney disease are at risk for adverse drug reactions. While the apps MyMedRec and eKidneyCare both aim to promote medication safety and allow users to share data with clinicians, eKindneyCare was found to be significantly more effective, according to a study published in the Clinical Journal of the American Society of Nephrology.
In a randomized one-year study, 182 patients with chronic kidney disease received a smartphone with eKidneyCare or MyMedRec. MyMedRec allows users to store medication and health information, which can be shared with providers. EKidneyCare prompts users to review their medication monthly and report changes or medication problems to their clinician.
Data found that 72 percent of eKidneyCare users completed at least one monthly medication review. For MyMedRec app users, only 30 percent of users kept their medication profiles on their phones.
The researchers concluded eKidneyCre significantly reduced the frequency and severity of medication discrepancies in patients with chronic kidney disease compared to MyMedRec.